ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY

Aim. To evaluate the effect of imidasoline agonist, rilmenidine (Albarel), on 24-hour blood pressure (BP) profile and autonomic regulation of cardiovascular system in young patients with arterial hypertension (HT) and exogenous constitutional obesity (ECO).Material and methods. The study included 80...

Full description

Saved in:
Bibliographic Details
Main Authors: N. N. Nikitina, A. G. Avtandilov, K. R. Petrosyan, S. L. Petrosov
Format: Article
Language:English
Published: Столичная издательская компания 2015-12-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/410
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227920507142144
author N. N. Nikitina
A. G. Avtandilov
K. R. Petrosyan
S. L. Petrosov
author_facet N. N. Nikitina
A. G. Avtandilov
K. R. Petrosyan
S. L. Petrosov
author_sort N. N. Nikitina
collection DOAJ
description Aim. To evaluate the effect of imidasoline agonist, rilmenidine (Albarel), on 24-hour blood pressure (BP) profile and autonomic regulation of cardiovascular system in young patients with arterial hypertension (HT) and exogenous constitutional obesity (ECO).Material and methods. The study included 80 men aged 18-32 ( average age 20,5 years), including 34 patients with HT and normal body weight, 36 patients with HT and ECO, 10 healthy men as a control group. All hypertensive patients were treated with rilmenidine 1-2 mg daily during 12 weeks. BP 24-hour profile and heart rate variability (HRV) were estimated before and after therapy.Results. Rilmenidine monotherapy resulted in significant reduction in average 24-hour, day-time and night-time BP as well as indices of BP loading in both groups. Indices of HRV proved the initial sympathetic overdrive among hypertensive patients especially among those with ECO. This sympathetic overdrive significantly reduced after 12 weeks of therapy.Conclusion. Rilmenidine effectively controls BP and reduces sympathetic system overdrive in young hypertensive patients with ECO.
format Article
id doaj-art-173dd80864364bea9e6a970c8ec3db81
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2015-12-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-173dd80864364bea9e6a970c8ec3db812025-08-23T10:00:19ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-0132434710.20996/1819-6446-2007-3-2-43-47410ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPYN. N. Nikitina0A. G. Avtandilov1K. R. Petrosyan2S. L. Petrosov3Russian Medical Academy of postgraduate education, MoscowRussian Medical Academy of postgraduate education, MoscowRussian Medical Academy of postgraduate education, MoscowRussian Medical Academy of postgraduate education, MoscowAim. To evaluate the effect of imidasoline agonist, rilmenidine (Albarel), on 24-hour blood pressure (BP) profile and autonomic regulation of cardiovascular system in young patients with arterial hypertension (HT) and exogenous constitutional obesity (ECO).Material and methods. The study included 80 men aged 18-32 ( average age 20,5 years), including 34 patients with HT and normal body weight, 36 patients with HT and ECO, 10 healthy men as a control group. All hypertensive patients were treated with rilmenidine 1-2 mg daily during 12 weeks. BP 24-hour profile and heart rate variability (HRV) were estimated before and after therapy.Results. Rilmenidine monotherapy resulted in significant reduction in average 24-hour, day-time and night-time BP as well as indices of BP loading in both groups. Indices of HRV proved the initial sympathetic overdrive among hypertensive patients especially among those with ECO. This sympathetic overdrive significantly reduced after 12 weeks of therapy.Conclusion. Rilmenidine effectively controls BP and reduces sympathetic system overdrive in young hypertensive patients with ECO.https://www.rpcardio.online/jour/article/view/410arterial hypertensionyoung ageobesityambulatory blood pressure monitoringheart rate variabilityrilmenidine
spellingShingle N. N. Nikitina
A. G. Avtandilov
K. R. Petrosyan
S. L. Petrosov
ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
Рациональная фармакотерапия в кардиологии
arterial hypertension
young age
obesity
ambulatory blood pressure monitoring
heart rate variability
rilmenidine
title ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
title_full ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
title_fullStr ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
title_full_unstemmed ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
title_short ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
title_sort arterial hypertension in young people efficacy of sympatholytic therapy
topic arterial hypertension
young age
obesity
ambulatory blood pressure monitoring
heart rate variability
rilmenidine
url https://www.rpcardio.online/jour/article/view/410
work_keys_str_mv AT nnnikitina arterialhypertensioninyoungpeopleefficacyofsympatholytictherapy
AT agavtandilov arterialhypertensioninyoungpeopleefficacyofsympatholytictherapy
AT krpetrosyan arterialhypertensioninyoungpeopleefficacyofsympatholytictherapy
AT slpetrosov arterialhypertensioninyoungpeopleefficacyofsympatholytictherapy